〜 Message from the President and CEO 〜

From April 1986 to September 2023, I worked for a Japan-based global pharmaceutical company for 31 years and for a US-based global CRO for 6.5 years, most of which time was spent in drug clinical development in Japan and Asia.

We founded t2T Healthcare Inc. in October 2023 so that we can contribute more flexibly and directly to many companies and organizations using our experience, know-how and network in drug development/regulatory affairs/sales & marketing, which we have cultivated.

This foundation is an extension of the web magazine “Drug R&D Expert” which was launched jointly with Japanese and Chinese colleagues in July 2021.  For example, Japan and China are neighbors in Asia, and both are leading players in the pharmaceutical R&D and market, but in talking with friends from both countries, we feel that there are actually many things that Japan and China seem to know about each other but do not.

We hope that our experience, know-how, and network will reduce the barriers between China, other Asian countries, Europe and the United States, and Japan, and that we can serve as a bridge for people around the world to trust each other and work together smoothly.

We desire to help patients in countries and regions around the world who are waiting for new medicines in any way we can.

〜 Corporate Information 〜